Menu
ÚHKT

Impaktované publikace

[1]

Hruba, P.; Brabcova, I.; Gueler, F.; Krejcik, Z.; Stranecky, V.; Svobodova, E.; Maluskova, J.; Gwinner, W.; Honsova, E.; Lodererova, A.; Oberbauer, R.; Zachoval, R.; Viklicky, O.

Molecular diagnostics identifies risks for graft dysfunction despite borderline histologic changes

[rok vydání 2015, impact factor 7.683 ]

[2]

Vaisocherová, H.; Šípová, H.; Víšová, I.; Bocková, M.; Špringer, T.; Laura Ermini, M.; Song, X.; Krejčík, Z.; Chrastinová, L.; Pastva, O.; Pimková, K.; Dostálová Merkerová, M.; Dyr, J.E.; Homola, J.

Rapid and sensitive detection of multiple microRNAs in cell lysate by low-fouling surface plasmon resonance biosensor

[rok vydání 2015, impact factor 7.476 ]

[3]

Merkerova, M.D.; Remesova, H.; Krejcik, Z.; Loudova, N.; Hrustincova, A.; Szikszai, K.; Cermak, J.; Jonasova, A.; Belickova, M.

Relationship between altered miRNA expression and DNA methylation of the DLK1-DIO3 region in azacitidine-treated patients with myelodysplastic syndromes and acute myeloid leukemia with myelodysplasia-related changes

[rok vydání 2018, impact factor 5.656 ]

[4]

Wohlfahrtova, M.; Hruba, P.; Klema, J.; Novotny, M.; Krejcik, Z.; Stranecky, V.; Honsova, E.; Vichova, P.; Viklicky, O.

Early isolated V-lesion may not truly represent rejection of the kidney allograft

[rok vydání 2018, impact factor 5.237 ]

[5]

Hruba, P.; Krejcik, Z.; Dostalova Merkerova, M.; et al.

Molecular fingerprints of borderline changes in kidney allografts are influenced by donor category

[rok vydání 2020, impact factor 5.085 ]

[6]

Hájková, H.; Fritz, M.H-Y.; Haškovec, C.; Schwarz, J.; Šálek, C.; Marková, J.; Krejčík, Z.; Dostálová Merkerová, M.; Kostečka, A.; Vostrý, M.; Fuchs, O.; Michalová, K.; Cetkovský, P.; Beneš, V.

CBFB - MYH11 hypomethylation signature and PBX3 differential methylation revealed by targeted bisulfite sequencing in patients with acute myeloid leukemia

[rok vydání 2014, impact factor 4.812 ]

[7]

Dostalova Merkerova, M.; Krejcik, Z.; Votavova, H.; Belickova, M.; Vasikova, A.; Cermak, J.

Distinctive microRNA expression profiles in CD34+ bone marrow cells from patients with myelodysplastic syndrome

[rok vydání 2010, impact factor 4.400]

[8]

Hrustincova, A.; Krejcik, Z.; Kundrat, D.; Szikszai, K.; Belickova, M.; Pecherkova, P.; Klema, J.; Vesela, J.; Hruba, M.; Cermak, J.; Hrdinova, T.; Krijt, M.; Valka, J.; Jonasova, A.; Merkerova, M.D.

Circulating small noncoding RNAs have specific expression patterns in plasma and extracellular vesicles in myelodysplastic syndromes and are predictive of patient outcome

[rok vydání 2020, impact factor 4.366 ]

[9]

Hruba, P.; Krejcik, Z.; Stranecky, V.; et al.

Molecular patterns discriminate accommodation and subclinical antibody-mediated rejection in kidney transplantation

[rok vydání 2019, impact factor 4.264 ]

[10]

Týcová, I.; Sulková, S.D.; Štěpánková, J.; Krejčík, Z.; Merkerová, M.D.; Stránecký, V.; Hrubá, P.; Girmanová, E.; Černoch, M.; Lipár, K.; Marada, T.; Povýšil, C.; Viklický, O.

Molecular patterns of diffuse and nodular parathyroid hyperplasia in long-term hemodialysis

[rok vydání 2017, impact factor 4.142 ]

[11]

Lhotska, H.; Zemanova, Z.; Cechova, H.; Ransdorfova, S.; Lizcova, L.; Kramar, F.; Krejcik, Z.; Svobodova, K.; Bystricka, D.; Hrabal, P.; Dohnalova, A.; Michalova, K.

Genetic and epigenetic characterization of low-grade gliomas reveals frequent methylation of the MLH3 gene

[rok vydání 2015, impact factor 3.960 ]

[12]

Sarova, I.; Brezinova, J.; Zemanova, Z.; Bystricka, D.; Krejcik, Z.; Soukup, P.; Cetkovsky, P.; Vydra, J.; Cermak, J.; Jonasova, A.; Michalova, K.

Characterization of chromosome 11 breakpoints and the areas of deletions and amplifications in newly diagnosed acute myeloid leukemia

[rok vydání 2012, impact factor 3.836 ]

[13]

Votavova, H.; Dostalova Merkerova, M.; Fejglova, K.; Vasikova, A.; Krejcik, Z.; Pastorkova, A.; Tabashidze, N.; Topinka, J.; Veleminsky, M. Jr.; Sram, R.J.; Brdicka, R.

Transcriptome alterations in maternal and fetal cells induced by tobacco smoke

[rok vydání 2011, impact factor 3.693 ]

[14]

Dostalova Merkerova, M.; Bystricka, D.; Belickova, M.; Krejcik, Z.; Zemanova, Z.; Polak, J.; Hajkova, H.; Brezinova, J.; Michalova, K.; Cermak, J.

From cryptic chromosomal lesions to pathologically relevant genes: integration of SNP-array with gene expression profiling in myelodysplastic syndrome with normal karyotype

[rok vydání 2011, impact factor 3.546 ]

[15]

Anděl, M.; Kléma, J.; Krejčík, Z.

Network-constrained forest for regularized classification of omics data

[rok vydání 2015, impact factor 3.503 ]

[16]

Šestáková, Š.; Krejčík, Z.; Folta, A.; Cerovská, E.; Šálek, C.; Dostálová Merkerová, M.; Pecherková, P.; Ráčil, Z.; Mayer, J.; Cetkovský, P.; Remešová, H.

DNA methylation and hydroxymethylation patterns in acute myeloid leukemia patients with mutations in DNMT3A and IDH1/2 and their combinations

[rok vydání 2019, impact factor 3.436 ]

[17]

Parikova, A.; Hruba, P.; Krejcik, Z.; Stranecky, V.; Franekova, J.; Krediet, R.T.; Viklicky, O.

Peritoneal dialysis induces alterations in the transcriptome of peritoneal cells before detectible peritoneal functional changes

[rok vydání 2020, impact factor 3.144 ]

[18]

Krejcik, Z.; Belickova, M.; Hrustincova, A.; Votavova, H.; Jonasova, A.; Cermak, J.; Dyr, J.E.; Merkerova, M.D.

MicroRNA profiles as predictive markers of response to azacitidine therapy in myelodysplastic syndromes and acute myeloid leukemia

[rok vydání 2018, impact factor 2.859 ]

[19]

Bystricka, D.; Sarova, I.; Zemanova, Z.; Brezinova, J.; Lizcova, L.; Izakova, S.; Dostalova-Merkerova, M.; Krejcik, Z.; Siskova, M.; Jonasova, A.; Neuwirtova, R.; Cerna, O.; Cermak, J.; Michalova, K.

Recurrent chromosomal breakpoints in patients with myelodysplastic syndromes and complex karyotype versus fragile sites

[rok vydání 2011, impact factor 2.764 ]

[20]

Zemanova, Z.; Michalova, K.; Buryova, H.; Brezinova, J.; Kostylkova, K.; Bystricka, D.; Novakova, M.; Sarova, I.; Izakova, S.; Lizcova, L.; Ransdorfova, S.; Krejcik, Z.; Dostalova Merkerova, M.; Dohnalova, A.; Siskova, M.; Jonasova, A.; Neuwirtova, R.; Cermak, J.

Involvement of deleted chromosome 5 in complex chromosomal aberrations in newly diagnosed myelodysplastic syndromes (MDS) is correlated with extremely adverse prognosis

[rok vydání 2014, impact factor 2.692 ]